Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Neurologia I Neurochirurgia Polska|August 13, 2003
[Primary leptomeningeal sarcomatosis. Case report]Arkadiusz Weglewski, Jacek Juryńczyk, Wielisław PapierzBulletin of the National Research Centre|January 16, 2023
Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case reportStefan Gustavsen, Mette Maria Nordling, Arkadiusz WeglewskiNeurologia I Neurochirurgia Polska|August 13, 2005
[Changes of protein S100B serum concentration during ischemic and hemorrhagic stroke in relation to the volume of stroke lesion]Arkadiusz Weglewski, Danuta Ryglewicz, Anna Mular, et al.Thrombosis Research|August 17, 2025
Iron deficiency anemia as a risk factor associated with stroke and cerebral venous thrombosis in children and adults - a systematic reviewMai Erritzøe-Jervild, Christina Kruuse, Arkadiusz Weglewski, et al.Ugeskrift for Laeger|May 14, 2020
[Carbon monoxide poisoning and development of delayed neuropsychiatric syndrome in a 77-year-old woman]Sahla El Mahdaoui, Christian Stenør, Arkadiusz Weglewski, et al.Plos One|May 18, 2021
Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis RegistryViktoria Papp, Mathias Due Buron, Volkert Siersma, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 5, 2024
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in DenmarkElisabeth Framke, Finn Sellebjerg, Matthias Kant, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 3, 2024
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish studyMie Reith Mahler, Melinda Magyari, Luigi Pontieri, et al.Neurology|March 17, 2019
Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort studyMathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg, et al.European Journal of Neurology|January 28, 2026
A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple SclerosisCamilla Maersk-Moller, Luigi Pontieri, Morten Leif Munding Stilund, et al.Pageof 2